Back

Osteopontin in colitis-associated carcinoma

Manna, S.; Sehn, M.; Cardoso da Silva, D.; Wiese, J. J.; Heldt, C.; Plumbom, I.; Conrad, T.; Husemann, C. C.; Kleo, K.; Derezanin, L.; Dony, V.; Farahani, S. K.; Weiss, F.; Kuehl, A. A.; Schallenberg, S.; Weiner, J.; Elezkurtaj, S.; Weixler, B.; Groene, J.; Siegmund, B.; Hummel, M.; Schumann, M.

2023-12-16 cancer biology
10.1101/2023.12.15.571952 bioRxiv
Show abstract

Patients with ulcerative colitis (UC) and Crohns disease (CD) face a lifelong risk of developing colitis-associated carcinoma (CAC). Current insights into CAC development originate from murine CAC models, while human CAC studies primarily focus on mutational analysis of patient samples. Although the mutational landscape reveals distinct patterns and frequencies compared to colorectal cancer, it falls short in elucidating the inflammatory mechanisms of CAC development. Consequently, we adopted a multi-omics approach to unravel CAC carcinogenesis from an immunological perspective. Our data revealed a robust upregulation of SPP1 gene in CAC at both RNA and protein levels, expressed by CD68+ macrophages. In vitro OPN stimulation demonstrated no direct effect on intestinal epithelial organoids. However, the mutually exclusive spatial location of SPP1/OPN+ macrophages and CD8+ T cells suggests a crucial indirect role of SPP1/OPN in mediating an immunosuppressive tumour microenvironment.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.